Cancer prevention and vitamin K antagonists: An overview

Thrombosis Research

Volumn 125, Issue , 2010, Pages S103-S105

  Pengo, Vittorio ^a   Denas, Gentian ^a   Jose, Seena Padayattil ^a   Pengo, Martino F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cancer; Prevention; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP; WARFARIN;

ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; NEOPLASM; REVIEW; THROMBOEMBOLISM;

ANIMALS; ANTICOAGULANTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; THROMBOEMBOLISM; VITAMIN K; WARFARIN;

EID: 77955487899     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70025-6     Document Type: Article

References (29)

1. Rickles, FR, Levine, MN, Venous Thromboembolism in Malignancy and Malig-nancy in Venous Thromboembolism. Haemostasis 28:Suppl S3 (1998), 43–49.
2. Hejna, M, Raderer, M, Zielinski, CC, Inhibition of metastases by anticoagulants. J Natl Cancer Inst 91 (1999), 22–36.
3. Bobek, V, Kovarík, J, Antitumor and antimetastatic effect of warfarin and heparins. Biomedicine & Pharmacotherapy 58 (2004), 213–219.
4. Smorenburg, SM, Van Noorden, CJ, The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev 53 (2001), 93–105.
5. Dvorak, HF, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986), 1650–1659.
6. Francis, JL, Biggerstaff, J, Amirkhosravi, A, Hemostasis and malignancy. Semin Thromb Hemost 24 (1998), 93–109.
7. Levine, MN, Lee, AY, Kakkar, AK, From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. J Thromb Haemost 1 (2003), 1456–1463 275 [pii].
8. Tilley, R, Mackman, N, Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost 32 (2006), 5–10.
9. Agostino, D, Cliffton, EE, Girolami, A, Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. Cancer 19 (1966), 284–288.
10. Brown, JM, A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. Cancer Res 33 (1973), 1217–1224.
11. Nash, GF, Walsh, DC, Kakkar, AK, The role of the coagulation system in tumour angiogenesis. Lancet Oncol 2 (2001), 608–613.
12. Mousa, SA, Anticoagulants in thrombosis and cancer: the missing link. Expert Rev Anticancer Ther 2 (2002), 227–233.
13. Rickles, FR, Patierno, S, Fernandez, PM, Tissue factor, thrombin, and cancer. Chest 124 (2003), 58S–68S.
14. Ryan, JJ, Ketcham, AS, Wexler, H, Warfarin treatment of mice bearing autochthonous tumors: effect on spontaneous metastases. Science 162 (1968), 1493–1494.
15. Lione, A, Bosmann, HB, The inhibitory effect of heparin and warfarin treatments on the intravascular survival of B16 melanoma cells in syngeneic C57 mice. Cell Biol Int Rep 2 (1978), 81–86.
16. Smorenburg, SM, Vink, R, Otten, HM, Swaneveld, F, Buller, HR, The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis. Thromb Haemost 86 (2001), 1586–1587.
17. Zacharski, LR, Henderson, WG, Rickles, FR, Forman, WB, Cornell, CJ Jr., Forcier, RJ, Edwards, R, Headley, E, Kim, SH, O'Donnell, JR, O'Dell, R, Tornyos, K, Kwaan, HC, Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA 245 (1981), 831–835.
18. Zacharski, LR, Henderson, WG, Rickles, FR, Forman, WB, Cornell, CJ Jr., Forcier, RJ, Edwards, RL, Headley, E, Kim, SH, O'Donnell, JF, et al. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 53 (1984), 2046–2052.
19. Chahinian, AP, Propert, KJ, Ware, JH, Zimmer, B, Perry, MC, Hirsh, V, et al. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol 7 (1989), 993–1002.
20. Daly, L, The first international urokinase/warfarin trial in colorectal cancer. Clin Exp Metastasis 9 (1991), 3–11.
21. Levine, M, Hirsh, J, Gent, M, Arnold, A, Warr, D, Falanga, A, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343 (1994), 886–889.
22. Maurer, LH, Herndon, JE 2nd, Hollis, DR, Aisner, J, Carey, RW, et al. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. J Clin Oncol 15 (1997), 3378–3387.
23. Blumentals, WA, Foulis, PR, Schwartz, SW, Mason, TJ, Does warfarin therapy influence the risk of bladder cancer?. Thromb Haemost 91 (2004), 801–805.
24. Taliani, MR, Agnelli, G, Prandoni, P, Becattini, C, Moia, M, Bazzan, M, et al. Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost 1 (2003), 1730–1733.
25. Schulman, S, Lindmarker, P, Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 342 (2000), 1953–1958.
26. Kuderer, NM, Khorana, AA, Lyman, GH, Francis, CW, A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer 110 (2007), 1149–1161.
27. Gerotziafas, GT, Papageorgiou, C, Hatmi, M, Samama, MM, Elalamy, I, Clinical studies with anticoagulants to improve survival in cancer patients. Pathophysiol Haemost Thromb 36 (2008), 204–211.
28. Cunningham, MS, Preston, RJ, O'Donnell, JS, Does antithrombotic therapy improve survival in cancer patients?. Blood Rev 23 (2009), 129–135.
29. Akl, EA, Kamath, G, Kim, SY, Yosuico, V, Barba, M, Terrenato, I, et al. Oral anticoagulation for prolonging survival in patients with cancer. Cochrane Database Syst Rev, 2007 CD006466.